Northwestern Mutual Wealth Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PBA
OAG
DM
DTC
SI
Northwestern Mutual Wealth Management's GMAB Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its Genmab (GMAB) stake by 50% in Q2 2026, selling an estimated $718 and leaving 27 shares worth $741. The position accounts for ﹤0.01% of the portfolio, ranked #3835.
Northwestern Mutual Wealth Management first reported a position in GMAB in Q3 2019 and has held it in 23 quarters since. The position peaked at $224K in Q4 2021. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- Northwestern Mutual Wealth Management held 27 shares of Genmab worth $741 as of Q2 2026.
- Northwestern Mutual Wealth Management sold 27 Genmab shares in Q2 2026, an estimated $718.
- Genmab made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3835 holding.
- Northwestern Mutual Wealth Management first reported a position in Genmab in Q3 2019 and has held it in 23 quarters since.
- Northwestern Mutual Wealth Management's Genmab position peaked at $224K in Q4 2021.
- 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.